Prognostic significance of pre-operative C-reactive protein and the neutrophil-lymphocyte ratio in resectable pancreatic cancer: a systematic review
about
Systemic inflammation response index (SIRI) predicts prognosis in hepatocellular carcinoma patients.Systemic Inflammatory Response and Elevated Tumour Markers Predict Worse Survival in Resectable Pancreatic Ductal AdenocarcinomaAdditive value of pre-operative and one-month post-operative lymphocyte count for death-risk stratification in patients with resectable pancreatic cancer: a multicentric study.Preoperative Neutrophil-Lymphocyte and Lymphocyte-Monocyte Ratios Reflect Immune Cell Population Rearrangement in Resectable Pancreatic Cancer.Expression of PRR11 protein and its correlation with pancreatic cancer and effect on survival.Increased neutrophil-to-lymphocyte ratio after neoadjuvant therapy is associated with worse survival after resection of borderline resectable pancreatic ductal adenocarcinoma.A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapy.Pretreatment C-reactive protein/albumin ratio is associated with poor survival in patients with stage IB-IIA cervical cancer.Neutrophil/lymphocyte ratio is a more sensitive systemic inflammatory response biomarker than platelet/lymphocyte ratio in the prognosis evaluation of unresectable pancreatic cancer.Prognostic value of preoperative neutrophil-to-lymphocyte ratio in Crohn's disease.Prognostic value of platelet-to-lymphocyte ratio in pancreatic cancer: a comprehensive meta-analysis of 17 cohort studies.The Predictive Value of Inflammation-Related Peripheral Blood Measurements in Cancer Staging and Prognosis.C-Reactive protein: a major inflammatory biomarkerIdentifying the role of neutrophil-to-lymphocyte ratio and platelets-to-lymphocyte ratio as prognostic markers in patients undergoing resection of pancreatic ductal adenocarcinoma
P2860
Q33798673-26ACE050-833D-4C07-B8B5-6C54A8841990Q36134440-26DE8EB9-9706-4D37-84C6-83BDC6A7920CQ36174677-ACEF493D-AFB2-49C6-931B-88EC98035780Q37639239-03DBCBF4-1D0B-42B0-96BD-A7F2C1F2BA3EQ38733788-8AAF1BBB-B83C-42AA-974D-EBD93C334F3BQ40510647-66A49761-E797-4D7B-B445-DEA3D3BDC0A0Q40766189-42735C74-C7B1-4B72-B31D-233E3CDFB53CQ47295549-A8770906-6A6F-475C-B59D-DB7999A6AB05Q49191186-F6FC8F8C-5D0A-4D6A-AA6C-825308D66DDBQ50051105-AE6B0ED4-2282-4F1A-8E64-8C0CCD9D9CDBQ52579384-766F147E-886C-432F-80F8-01848F5335AFQ52605888-86F5D369-86A5-4BA3-AF68-92C7D9D90BD8Q57818432-AD35D398-03DA-48F2-891A-36D250C8DA68Q58781336-27B37AEC-C61C-477D-AE24-D4C4C747DDC4
P2860
Prognostic significance of pre-operative C-reactive protein and the neutrophil-lymphocyte ratio in resectable pancreatic cancer: a systematic review
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Prognostic significance of pre ...... ic cancer: a systematic review
@ast
Prognostic significance of pre ...... ic cancer: a systematic review
@en
type
label
Prognostic significance of pre ...... ic cancer: a systematic review
@ast
Prognostic significance of pre ...... ic cancer: a systematic review
@en
prefLabel
Prognostic significance of pre ...... ic cancer: a systematic review
@ast
Prognostic significance of pre ...... ic cancer: a systematic review
@en
P2093
P2860
P50
P356
P1476
Prognostic significance of pre ...... ic cancer: a systematic review
@en
P2093
Andrew M Smith
Christian Macutkiewicz
Lewis Stevens
Samir Pathak
P2860
P304
P356
10.1111/HPB.12355
P577
2014-11-27T00:00:00Z